Pulmonary Disease, Chronic Obstructive

Respiratory·MeSH: Pulmonary Disease, Chronic Obstructive

Prevalence

2781.7 / 100K

Incidence

215.5 / 100K/yr

4 drugs in development·3 companies·9 clinical trials

Drug Pipeline by Phase

Compare drugs

Frequently asked questions

How many drugs are in development for Pulmonary Disease, Chronic Obstructive?

BioSniper tracks 4 drugs in development for Pulmonary Disease, Chronic Obstructive across 3 companies.

How many clinical trials target Pulmonary Disease, Chronic Obstructive?

There are 9 clinical trials targeting Pulmonary Disease, Chronic Obstructive tracked by BioSniper.

What is the prevalence of Pulmonary Disease, Chronic Obstructive?

The estimated prevalence of Pulmonary Disease, Chronic Obstructive is approximately 2781.7 per 100,000 population.

Deep-dive into Pulmonary Disease, Chronic Obstructive

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Pulmonary Disease, Chronic Obstructive — Drugs in Development & Clinical Trials | BioSniper